Pfizer's Sutent Gets Approval

The Food and Drug Administration on Thursday approved a Pfizer (PFE Quote) drug for treating advanced kidney cancer and a rare form of stomach cancer.

Although FDA approval had been expected for the drug Sutent, the announcement gave Pfizer a second dose of good news. Earlier in the day, the European Union approved Exubera, an inhaled form of insulin, developed by Pfizer and Nektar Therapeutics (NKTR Quote).

The FDA might rule Friday on the companies' Exubera application in the U.S. ...